Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

OBJECTIVE: To assess the efficacy, safety, and tolerability of cariprazine in the treatment of the depressed phase of bipolar I disorder in adults (NCT02670538). METHODS: In this phase 3 double‐blind placebo‐controlled study, adult patients with bipolar I disorder according to the Diagnostic and Sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Earley, Willie R., Burgess, Maria V., Khan, Barbara, Rekeda, Ludmyla, Suppes, Trisha, Tohen, Mauricio, Calabrese, Joseph R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318333/
https://www.ncbi.nlm.nih.gov/pubmed/31628698
http://dx.doi.org/10.1111/bdi.12852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318333/
https://www.ncbi.nlm.nih.gov/pubmed/31628698
http://dx.doi.org/10.1111/bdi.12852

Ejemplares similares